Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 19 of 29
-
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
On 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
-
Politics of Death: The End of Brazil’s Department of AIDS
Adapted from a post published by ABIA, Global AIDS Policy Watch: A joint story from Brazilian NGOs that have denounced...
-
Pipeline patents – Brazilian Supreme Court decides on the present and the future
On Wednesday 22 May, the largest trial in the history of the Brazilian Federal Supreme Court (STF) involving the pharmaceutical...
-
Truvada for PrEP. Gilead grilled at US congressional hearing
The USA is being charged $70 per pill for a drug, yet tax payers largely funded the research. Thanks to...
-
What’s wrong with IP rights? Protecting medicines from competition can be costly
Gram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...
-
Activists file post-grant opposition challenging a patent preventing purchase of cheaper treatment for hepatitis C
GTPI has presented an argument to the Brazilian Patent Office (INPI) to invalidate the patent granted for the drug daclatasvir....
-
Kularb’s story: Optimal treatment would reduce HIV-related stigma
Interview by Gemma Taylor. “I was told I’d have to wait for 10 more people to die before I could...
-
Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
The All-Ukrainian Network of People Living with HIV/AIDS (the Network) has received an official letter from Merck, dated 15 March...
-
Watching Brazil: In defence of democracy and human rights
Author: Andresa Porto – Political Scientist and member of GTPI. Now that the Brazilian government’s new party blocs have been...
-
Watching Brazil. New monthly column analyzing the impact of Bolsonaro’s politics on civil society and access to medicines
Author: Andresa Porto – Political Scientist and member of GTPI. Translated from Portuguese, original version here. This is the first...
-
Action against AbbVie. Money that could treat HIV patients ‘goes up in smoke’ in Kiev
Activists gathered outside a Kiev Court to highlight the huge amount of money being wasted on an overpriced drug, due...
-
Looking back to build on our success. Making more medicines affordable in 2019
We’re gearing up for the next, expanded phase of our campaign. We’re determined that pharmaceutical companies and governments must #TreatPeopleRight...